SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-20-000019
Filing Date
2020-06-24
Accepted
2020-06-23 17:35:11
Documents
14
Period of Report
2020-06-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20200619.htm   iXBRL 8-K 45451
  Complete submission text file 0001358403-20-000019.txt   191148

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20200619.xsd EX-101.SCH 2423
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20200619_cal.xml EX-101.CAL 710
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20200619_def.xml EX-101.DEF 1643
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20200619_lab.xml EX-101.LAB 24993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20200619_pre.xml EX-101.PRE 13190
14 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20200619_htm.xml XML 11751
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 20983256
SIC: 2834 Pharmaceutical Preparations